| 2004N-0181 - Critical Path Initiative; Establishment of Docket | |||||||||||||||||||||||
| FDA Comment Number : | EC27 | ||||||||||||||||||||||
| Submitter : | Dr. Bess Dawson-Hughes | Date & Time: | 08/02/2004 07:08:03 | ||||||||||||||||||||
| Organization : | National Osteoporosis Foundation | ||||||||||||||||||||||
| Health Care Association | |||||||||||||||||||||||
| Category : | |||||||||||||||||||||||
| Issue Areas/Comments | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| Pursuant to comments sent to the docket by the National Osteoporosis Foundation and the American Society for Bone and Mineral Research, ASBMR no longer wishes to be a signature. Therefore, the National Osteoporosis Foundation is submitting comments on its own in the attached document. | |||||||||||||||||||||||